Editor’s Note: ivWatch is one of Hampton Roads’ fastest growing startups, and they’re solving a huge global problem to boot. Their story illustrates how critical it is to build a robust entrepreneurial ecosystem. From getting investment from 757 Angels to having flexible innovation-oriented spaces available like the Tech Center Research Park, and everything in between, before, and after—it all matters.
Join us in applauding Gary Warren and the entire ivWatch team. We look forward to providing continued coverage as their story develops!
ivWatch, a medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, announced the lease signing as the anchor organization of Newport News Tech Center Research Park’s Building One. The company is relocating from its Hampton headquarters and Williamsburg research & development (R&D) facility, combining all departments under one roof.
“The move signifies our ongoing investment in the region and aligns our strong history of medical innovation with this budding business and entrepreneurial community,” said Gary Warren, president and CEO of ivWatch. “The Research Park is the type of space we need to expand our clinical and R&D efforts, execute manufacturing and national and international distribution of our product, all while maintaining essential business functions like operations, sales and marketing.”
As the anchor tenant occupying more than 25,500 sq. ft., the building will include exterior ivWatch signage. The first-floor manufacturing space will be housed within sleek glass walls, and state-of-the-art R&D and office space will be located on the third floor.
The ivWatch move-in is slated to be complete by mid-2019, and a ribbon-cutting for Building One is planned for August 2019.
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians are able to leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit www.ivwatch.com.
ivWatch is pleased to sponsor the work of myIV.com, an online resource dedicated to empowering visitors with information on all things IV, simplified.
Direct (757) 224-2606
Office (855) 489-2824 x7007
Mobile (757) 660-4949
Have a story in mind or press release of your own that our regional entrepreneurs and innovators should know about? Let us know!
Stay updated on news and events in the Hampton Roads startup ecosystem…sign up for the StartWheel newsletter!
StartWheel’s mission is to centralize and mobilize efforts that foster the growth of entrepreneurism in our regional innovation economy. We aim to support and cultivate an entrepreneurial network in HRVA where talent, resources, information and leadership come together.